Dewpoint Therapeutics logo

Dewpoint Therapeutics, Inc.

Biotechnology

Dewpoint Therapeutics Stock

Dewpoint Therapeutics focuses on drug discovery across oncology, neurodegenerative, cardiopulmonary, and metabolic diseases using an AI-powered platform. It specializes in visualizing and targeting biomolecular condensates to prevent harmful protein aggregation, collaborating with top academic and pharmaceutical entities to develop innovative therapies.

For more Dewpoint Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Ameet Nathwani Chief Executive Officer & Board Member
Lori Escobedo Chief People Officer
Isaac Klein Chief Scientific Officer
Dean Mula Vice President & Corporate Controller
Anthony Hyman Co-Founder & Board Member
Richard Young Co-Founder & Board Member

Funding Information